Jazz Pharmaceuticals JAZZ
NASDAQ JAZZ
$235.67 +2.66 (+1.14%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jazz Pharmaceuticals (JAZZ) Income from Discontinued Operations (2012)

Updated

Jazz Pharmaceuticals' Income from Discontinued Operations was $34.35 million in Q4 2012.

Analysis

Jazz Pharmaceuticals (JAZZ) Income from Discontinued Operations (2012) Analysis & Trends

For FY2012, Income from Discontinued Operations at Jazz Pharmaceuticals came in at $27.44 million.

  • Per Business Quant data, JAZZ's Income from Discontinued Operations in the three quarters before Q4 2012 was -$386,000 (Q3 2012), -$3.97 million (Q2 2012) and -$2.55 million (Q1 2012).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Jazz Pharmaceuticals 15.30 Bn 9.12 Bn 1.09 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 34.35 Mn
Sep 30, 2012 -386,000.00
Jun 30, 2012 -3.97 Mn
Mar 31, 2012 -2.55 Mn
API Access

Jazz Pharmaceuticals Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=JAZZ&period=max&api_key=YOUR_API_KEY